Clinical Guidelines for the Safe Use of McKinley T34 Syringe Pump

Lateral aspects of upper arms and thighsBack (scapula) -particularly suitable for confused patientsII. Areas which should not be used for syringe pump infusion Lymph oedematous limbs or trunk Sites over bony prominences Sites near a joint Previously irradiated skin Infected skin/skin lesionsCARE OF INFUSION SITENo Action Rationale1 A transparent dressing must be used. To permit visible monitoring ofsite.2 If there is evidence of inflammation or poorabsorption (hard subcutaneous swelling), theinfusion site should be renewed.3 The needle site should be changed at leastevery 3 days.4 Inspect for leakage at the cannula site and atthe connection sites.This may effect absorption ofmedication and patient comfortTo reduce the risk of irritation /inflammation / cannula displacement.In order to minimise the risk of anymalfunction or administrationproblems.SITE BREAKDOWNNo Action Rationale1 Further dilute drug if possible To reduce any site irritation2 Change infusion device, e.g. Thalus set ifpatient has allergy to metal (Unomedical -available through NHS Logistics).To reduce any site reaction andprevent absorption problems.3 Change type of site dressing To reduce any site irritation4 Change site more often To reduce any site reaction.5 Check diluent To ensure the appropriate diluentis used.6 Check compatibility of drugs. (Seek advicefrom a pharmacist on whether an alternativediluent would be appropriate).To reduce the possibility of druginteractions.7 Consider the use of an additional pump. To reduce any possible druginteractions.Page 18 of 33